ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,337, issued on April 21, was assigned to Peking University (Beijing).

"Nanoparticle drug targeting JFK and use thereof" was invented by Luyang Sun (Beijing), Zhaofei Liu (Beijing), Lin He (Beijing), Yongfeng Shang (Beijing), Chao Gao (Beijing) and Shimiao Yu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A nanoparticle drug based on a small interfering RNA (siRNA) targeting JFK and use thereof are provided. Nucleotide sequences of the sense strand the antisense strand of the siRNA targeting JFK are set forth in SEQ ID NO: 1 and SEQ ID NO: 2, respectively. Liposomes can be used to encapsulate the complex of the siRNA and a protamine to prod...